Developmental Effects of Infant Formula Supplemented With LCPUFA

The purpose of this study is to compare the effects on visual development, growth, cognitive development, tolerance, and blood chemistry parameters in term infants fed one of four study formulas containing various levels of DHA and ARA.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cognitive Development Growth

Age range

1 day–5 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Kansas Medical Center, Kansas City, Kansas, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy, term, formula fed infants from 1-5 days of age

Exclusion criteria

history of disease that effects normal growth and development
breast fed, or formula intolerance

Treatment and study plan

DHA and ARA

Other

various levels of DHA and ARA

Control

Other

Primary outcomes

visual development

Secondary outcomes

Cognitive development

Sponsors and collaborators

Lead sponsor

Mead Johnson Nutrition

Industry

Registry information

Important dates

First posted: Sep 17, 2008
Registry last updated: Sep 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed